Insider Trading & Ownership - Eton Pharmaceuticals Inc. (ETON)

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Eton Pharmaceuticals Inc.
Goto Prev, 0, 1
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
Company Symbol Insider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2021-11-05
Sale
2021-11-09
4:46 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
220,362 $6.2533 $1,377,986 86,438
(Indirect)
View
2021-11-03
Sale
2021-11-05
4:13 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
202,200 $6.4911 $1,312,501 97,500
(Indirect)
View
2021-10-08
Sale
2021-10-13
07:57 am
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
165,100 $5.0313 $830,670 117,100
(Indirect)
View
2021-08-20
Purchase
2021-08-20
4:08 pm
Eton Pharmaceuticals Inc. ETON Troutman William Wilson
CFO, Treasurer & Secretary
5,000 $4.43 $22,150 23,027
(Direct)
View
2021-08-20
Purchase
2021-08-20
4:06 pm
Eton Pharmaceuticals Inc. ETON BRYNJELSEN SEAN
President & CEO
10,000 $4.32 $43,200 1,054,940
(Indirect
Direct)
View
2021-08-04
Sale
2021-08-06
9:53 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
604,500 $5.8283 $3,523,187 117,100
(Indirect)
View
2021-06-15
Sale(A)
2021-06-21
06:05 am
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
105,000 $8.07 $847,350 141,600
(Indirect)
View
2021-06-15
Sale
2021-06-17
4:39 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
105,000 $8.07 $847,350 141,600
(Indirect)
View
2021-06-03
Purchase
2021-06-03
12:11 pm
Eton Pharmaceuticals Inc. ETON BRYNJELSEN SEAN
President & CEO
5,000 $5.96 $29,800 1,054,940
(Indirect
Direct)
View
2021-05-25
Sale
2021-05-27
7:34 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
242,300 $8.5205 $2,064,511 145,600
(Indirect)
View
2021-04-12
Sale
2021-04-12
7:55 pm
Eton Pharmaceuticals Inc. ETON HARROW HEALTH INC.
10% Owner
1,518,000 $7 $10,626,000 1,982,000
(Direct)
View
2020-10-16
Purchase
2020-10-16
9:30 pm
Eton Pharmaceuticals Inc. ETON Opaleye Management Inc.
10% Owner
400,000 $7 $2,800,000 155,000
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
Company Symnbol Insider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2021-05-03
Option Award
2021-05-05
4:16 pm
N/A
2031-05-03
Eton Pharmaceuticals Inc. ETON CASAMENTO CHARLES J
Director
19,655 $0 59,555
(Direct)
View
2021-05-03
Option Award
2021-05-05
4:16 pm
N/A
2031-05-03
Eton Pharmaceuticals Inc. ETON BRYNJELSEN SEAN
President & CEO
245,000 $0 1,185,000
(Direct)
View
2021-05-03
Option Award
2021-05-05
4:15 pm
N/A
2031-05-03
Eton Pharmaceuticals Inc. ETON RIEDEL NORBERT G
Director
19,655 $0 59,555
(Direct)
View
2021-05-03
Option Award
2021-05-05
4:15 pm
N/A
2031-05-03
Eton Pharmaceuticals Inc. ETON Troutman William Wilson
CFO and Secretary
125,000 $0 656,200
(Direct)
View
2021-05-03
Option Award
2021-05-05
4:15 pm
N/A
2031-05-03
Eton Pharmaceuticals Inc. ETON Adams Jennifer McKie
Director
28,133 $0 28,133
(Direct)
View
2021-05-03
Option Award
2021-05-05
4:15 pm
N/A
2031-05-03
Eton Pharmaceuticals Inc. ETON MAIER PAUL V
Director
19,655 $0 59,555
(Direct)
View
2020-03-19
Ownership
2021-02-16
08:59 am
N/A
N/A
Eton Pharmaceuticals Inc. ETON CASAMENTO CHARLES J
Director
3,500 $0 68,420
(Direct)
View
(A) Indicate amendment filing.
Goto Prev, 0, 1